本頁只刊出中文翻譯與中文說明；英文原文請見下方原文連結。
原文連結
論文資訊
- 類型：已發表論文
- 日期：2016-10-21
摘要
Aim. There is firm evidence of a relation between type 2 diabetes (T2DM) and increased risks of 癌症 at various sites, but it is still unclear how different antihyperglycaemic therapies modify site-specific 癌症 risks. The aim of this study was to provide a complete characterization of all possible associations between individual T2DM therapies, statin use and site-specific 癌症s in the Austrian 族群. Methods. Medical claims data of 1 847 051 patients with hospital stays during 2006-2007 were used to estimate age-and sex-dependent co-occurrences of site-specific 癌症 diagnoses and treatment with specific glucose-lowering drugs and statins. Results. Patients treated with insulin or insulin secretagogues showed up to ninefold increased risks for 癌症s of the colon [males only (m)], liver (m), pancreas,
※ 此為已發表論文，全文需透過期刊付費取得